Coya Therapeutics Inc. (COYA)
undefined
undefined%
At close: undefined
5.89
2.26%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue 6.00M - - -
Cost of Revenue 27.36K 27.36K 16.13K -
Gross Profit 5.97M -27.36K -16.13K -
Operating Income -7.90M -9.81M -4.87M -694.77K
Interest Income - - - 58.46
Pretax Income -7.26M -12.24M -4.89M -733.20K
Net Income -7.99M -14.68M -4.87M -733.20K
Selling & General & Admin 7.83M 4.85M 2.31M 445.80K
Research & Development 5.50M 4.94M 2.54M 248.97K
Other Expenses 570.55K 27.36K 16.13K -
Operating Expenses 13.91M 9.81M 4.87M 694.77K
Interest Expense - 2.43M - 38.98K
Selling & Marketing Expenses - - - 445.13K
Cost & Expenses 13.91M 9.81M 4.87M 694.77K
Income Tax 723.85K 2.43M -21.48K -704.65
Shares Outstanding (Basic) 10.16M 9.95M 9.68M 9.68M
Shares Outstanding (Diluted) 10.16M 9.95M 9.68M 9.68M
EPS (Basic) -0.79 -1.48 -0.5 -0.08
EPS (Diluted) -0.79 -1.48 -0.5 -0.08
EBITDA -7.90M -12.22M -4.85M 10.44K
Depreciation & Amortization 27.36K 27.36K 16.13K 704.65K